Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay

Journal of Clinical Microbiology

Volumn 40, Issue 5, 2002, Pages 1761-1766

  Kolk, Daniel P ^a   Dockter, Janel ^a   Linnen, Jeff ^a   Ho Sing Loy, Marcy ^a   Gillotte Taylor, Kristin ^a   McDonough, Sherrol H ^a   Mimms, Larry ^a   Giachetti, Cristina ^a  

^a Gen Probe Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; VIREMIA; VIRUS DETECTION;

BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS C; HIV SEROPOSITIVITY; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036246184     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.5.1761-1766.2002     Document Type: Article

References (16)

1. Will genome detection replace serology in blood screening for microbial agents?
2. Genomic screening for blood-borne viruses in transfusion settings
3. Assay formats involving acridinium-ester-labeled DNA probes
4. Shortening of the diagnostic window with a new combined HIV p24 antigen and HIV-1/2/O screening test
5. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors
6. Blood screening by nucleic acid amplification technology: Current issues, future challenges
7. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay
8. The risks of transfusion-transmitted infection: Direct estimation and mathematical modelling
9. Advantages of 2′-Omethyl oligoribonucleotide probes for detecting RNA targets
10. High throughput assay for the simultaneous or separate detection of human immunodeficiency virus (HIV) and hepatitis type C virus (HCV)
11. Simultaneous detection of multiple nucleic acid targets in a homogeneous format
12. NAT of the United States and Canadian blood supply
13. Hepatitis C-diagnosis and monitoring
14. Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay